

Actos (pioglitazaone) has recently been associated with the risk of bladder cancer, according to the FDA.On August 4, 2011, the FDA approved updated drug labels for the pioglitazone-containing medicines to include safety information that continued use of this medication for more than one year can be associated with an increased risk of bladder cancer.
The updated drug labels now include the following information:
· Not to use pioglitazone in patients with active baldder cancer; and
· Use pioglizaone with caution in patients with a prior history of bladder cancer.
These updated drug labels also recommend that patients should:
· “Contact their healthcare professional if they experience any sign of blood in the urine or a red color in the urine or other symptoms such as new or worsening urinary urgency or pain on urination since starting pioglitazone, as these may be due to bladder cancer.”
Actos has also been linked to heart failure risk and other serious side affects. Despite these risks, Actos has become the number one diabetes pill after Avandia. Takeda Pharmaceuticals Co. Ltd. is the manufacturer of Actos.
Currently, Nancy Rios, 54 years old, is suing Takeda, alleging that her recurrent bladder cancer is a direct result of using Actos. She has taken Actos for more than a decade. Rios lives in Penslyvania and is worried about being able to pay for her medical bills and missing additional time from work. She said, “I could lose my bladder and possibly need chemo.” Many others have suffered bladder cancer and serious side effects from taking Actos.
The FDA analyzed a study from the first five years of a ten year Actos safety study completed by Takedo in 2002. They concluded that the risk of bladder cancer was 40 percent higher for patients taking Actos for at least a year.
If you or a loved one has suffered a serious injury caused by a related Actos side effect, you may be able to be a part of the Actos Bladder Cancer Lawsuit and seek compensation for your losses and suffering. Our experienced attorneys will be glad to try and advise you.
Now that Actos has been shown to have the same damaging effect to the heart as Avandia you need attorneys who have dealt with this type of lawsuit and settlement before. The Gallagher Law Firm attorneys have handled many different drug injury and other medical injury cases over the last thirty years. Having handled Avandia cases they understand the injuries their clients received and their knowledge means they don’t have spend time learning about the injuries of Actos. Glaxo Smith Kline, the makers of Avandia have already set aside over 400 million dollars for settlements regarding Avandia. They recently stated they have settled ten thousand cases already.
According to Wikipedia, Actos which is a product of the pharmaceutical giant Takeda Pharmaceuticals, was the tenth best selling drug in the U.S. in 2008 with sales of over 2.4 Billion dollars. Many patients who had been on Avandia were switched to Actos believing it would be safer. Now, a study is showing it is not safer than Avandia. Those who have taken Actos and suffered heart or other injury as the result of it deserve to be compensated.
When a person discovers they have been injured by a medicine like Actos they need to act immediately to insure they preserve their rights under any claim. It is important to have attorneys who can guide you each step of the way and who will walk with you and talk with you through the entire process. The attorneys with The Gallagher Law Firm know how to get things moving and how to protect their clients because they are real attorneys who try cases and also get settlements. They are not “television” lawyers who are just advertising to sign the case away to someone else. Utilize the click to call feature and our firm will call you back, usually within minutes. If you would prefer a guide to how determine if you have a claim that deserves compensation, fill out the short amount of information to the right and we will email or mail you a packet with information on developing a claim and additional information about Actos.